Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Voyager Therapeut (NQ: VYGR )

6.545 -0.385 (-5.56%)
Streaming Delayed Price Updated: 3:05 PM EST, Dec 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Voyager Therapeut

< Previous 1 2 3 4 5 6 7 Next >
Top 10 DeFi Projects To Watch In 2022
By Voyager's Charlotte Siller, provided exclusive... 
Via Benzinga
Voyager Posts Encouraging Preclinical Data For CNS-Directed Gene Therapy
Voyager Therapeutics Inc (NASDAQ: VYGR) has announced the presentation of preclinical data of GBA1 gene replacement therapy. The data demonstrated that a single... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Dermata Therapeutics (NASDAQ:DRMA 
Via Benzinga
46 Biggest Movers From Yesterday
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’... 
Via Benzinga
Exposures Product Safety
Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher
Toward the end of trading on Monday, the Dow traded down 0.37% to 34,617.17 while the Nasdaq fell 0.05% to 34,617.14. The S&P 500 also fell, dropping 0.26% to 4,379.88. Let's look at what has happened... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher
Toward the end of trading Monday, the Dow traded down 0.37% to 34,617.17 while the NASDAQ fell 0.05% to 34,617.14. The S&P also fell, dropping 0.26% to 4,379.88. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares increased by 92.43% to $35.1 during Monday's regular session. Trading volume for this security as of 12:30 EST is... 
Via Benzinga
Mid-Day Market Update: Crude Oil Surges Over 2%; Supernus Pharmaceuticals To Acquire Adamas Pharmaceuticals
Midway through trading Monday, the Dow traded up 0.50% to 34,920.55 while the NASDAQ rose 0.50% to 34,920.55. The S&P also rose, gaining 0.44% to 4,410.73. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
28 Stocks Moving In Monday's Mid-Day Session
Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares moved upwards by 89.3% to $34.53 during Monday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
35 Biggest Movers From Friday
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers ChemoCentryx (NASDAQ:CCXI) stock increased by 70.43% to $33.41 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 74.6... 
Via Benzinga
Everything You Need To Know To Get Into DeFi
DeFi assets are getting a lot of recent attention from investors as they change the way we do business and take crypto transactions to the next fro... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
Upgrades For State Street Corporation (NYSE: 
Via Benzinga
40 Biggest Movers From Yesterday
Gainers Volcon, Inc. (NASDAQ: VLCN) shares jumped 97.5% to settle at $10.86 on Wednesday as the company priced its IPO at $5.50 per share. Voyager Therapeutics, Inc. (NASDAQ:... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers TransCode Therapeutics (NASDAQ:RNAZ 
Via Benzinga
Mid-Afternoon Market Update: US Stocks Turn Positive; Hovnanian Enterprises Shares Slide
Toward the end of trading Wednesday, the Dow traded up 0.08% to 34,342.65 while the NASDAQ rose 0.38% to 14,489.14. The S&P also rose, gaining 0.19% to 4,353.99. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
VYGR Stock: The Huge Licensing Deal Sending Voyager Therapeutics Rocketing Higher
Here's the big licensing news that's sending shares of VYGR stock higher today as investors reassess this company's value moving forward. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Voyager Therapeutics (NASDAQ:VYGR) shares moved upwards by 44.73% to $3.58 during Wednesday's regular session. Voyager Therapeutics's stock is trading at a... 
Via Benzinga
Mid-Day Market Update: Dow Tumbles Over 300 Points; Acer Therapeutics Shares Jump
Midway through trading Wednesday, the Dow traded down 0.92% to 33,997.95 while the NASDAQ fell 0.49% to 14,362.47. The S&P also fell, dropping 0.75% to 4,313.33. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
26 Stocks Moving In Wednesday's Mid-Day Session
Gainers Voyager Therapeutics, Inc. (NASDAQ: VYGR) shares jumped 54.1% to $3.8050 after the company announced licensing option agreement with Pfizer for capsids generated from... 
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; Acuity Brands Posts Upbeat Q4 Results
Following the market opening Wednesday, the Dow traded down 1.12% to 33,929.34 while the NASDAQ fell 0.69% to 14,334.78. The S&P also fell, dropping 0.90% to 4,306.41. The U.S... 
Via Benzinga
Topics Stocks
Exposures US Equities
Voyager Therapeutics Stock Soars On License Option Pact With Pfizer
Voyager Therapeutics Inc (NASDAQ: VYGR) has announced licensing option agreement with Pfizer Inc (NYSE: PFE) for capsids generated from Voyager's RNA... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Voyager Therapeutics (NASDAQ:VYGR) shares increased by 46.15% to $3.61 during Wednesday's pre-market session. The company's market cap stands at $136.9... 
Via Benzinga
5 Gene Therapy Stocks Back in Focus on AbbVie/Regenxbio Deal
Gene therapy is set to become one of the most vital spaces with high prospects in the biotech sector. 
Via Talk Markets
5 Value Stocks In The Healthcare Sector
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... 
Via Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... 
Via Benzinga
Exposures Product Safety
35 Stocks Moving In Monday's Mid-Day Session
Gainers Globalstar, Inc. (NYSE: GSAT) shares climbed 43.6% to $2.0535. GSAT shares traded higher following a note sent out by popular Apple Inc. (NASDAQ: AAPL) analyst Ming... 
Via Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (... 
Via Benzinga
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.